Martin A. Walter - Concepedia

Author

Martin A. Walter

Also Known As

Jair C. Soares, M A Walter, M Briel, M WALTER, M Walter, M. A. Walter, M. Walter, M.A. Walter, Martin A Walter, Martin A. Walter

184

Publications

9.1K

Citations

H-Index

101

Concepts

All Affiliations

University Hospital of Basel University Hospital of Bern McMaster University University of California, Los Angeles University of Basel

About

Martin A. Walter is an author at University Hospital of Basel specializing in medicine, oncology, and radiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	19	1.8K
2	Health Sciences	6	6	643
3	Engineering	2	2	123
4	Natural Sciences	2	2	183
5	Education	1	1	25

Martin A. Walter

Publications

8.1K

Citations

H-Index

Page 1

	Year	Citations
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis Douglas S. Ross, Henry B. Burch, David S. Cooper, Thyroid	2016	2.7K
Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [<sup>90</sup>Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers Anna Imhof, Philippe Brunner, Nicolas Marincek, Journal of Clinical Oncology	2011	616
Prevalence, Characteristics, and Publication of Discontinued Randomized Trials Benjamin Kasenda, Erik von Elm, John J. You, JAMA	2014	389
The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease Martin A. Walter, R Melzer, Christian Schindler, European Journal of Nuclear Medicine and Molecular Imaging Positron Emission TomographyVasculitisPet-mriVeterinary SciencePathology	2005	357
Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-Out Hartmut P.H. Neumann, Zoran Erlic, Carsten C. Boedeker, Cancer Research Neck Paraganglioma PatientsGenetic TestingGeneticsGenetic EpidemiologyPathology	2009	194
Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes <i>SDHA</i>, <i>TMEM127</i>, <i>MAX</i>, and <i>SDHAF2</i> for Gene-Informed Prevention Birke Bausch, Francesca Schiavi, Ying Ni, JAMA Oncology	2017	194
The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis Martin Fuchs, Matthias Briel, Thomas Daikeler, European Journal of Nuclear Medicine and Molecular Imaging Vascular DiseaseVasculitisCardiovascular DiseaseVeterinary ScienceMedicine	2011	193
Cohort Study of Somatostatin-Based Radiopeptide Therapy With [<sup>90</sup>Y-DOTA]-TOC Versus [<sup>90</sup>Y-DOTA]-TOC Plus [<sup>177</sup>Lu-DOTA]-TOC in Neuroendocrine Cancers Linda Villard, Anna Romer, Nicolas Marincek, Journal of Clinical Oncology	2012	184
1,2,3‐Triazoles as Amide Bond Mimics: Triazole Scan Yields Protease‐Resistant Peptidomimetics for Tumor Targeting Ibai E. Valverde, Andreas Bauman, Christiane A. Kluba, Angewandte Chemie International Edition Medicinal ChemistryBiochemistryAmide BondsNatural SciencesMedicine	2013	173
Response to [90Yttrium-DOTA]-TOC Treatment is Associated with Long-term Survival Benefit in Metastasized Medullary Thyroid Cancer: A Phase II Clinical Trial Fabienne Iten, Beat P. Müller‐Stich, Christian Schindler, Clinical Cancer Research	2007	165

Page 1